Razelle Kurzrock
0000-0003-4110-1214
Publication & Citation Trends
Publications
0 total
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations
Cited by 3
Semantic Scholar
Trojan horses at leptomeningeal cellular gates: Antibody-drug conjugates deliver cytotoxic payloads.
Cited by 0
Semantic Scholar
Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies
Cited by 0
Semantic Scholar
TIP26-317: A Single-arm, Open-label, Phase II Trial of Cemiplimab Plus Gemcitabine as Second-Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Harboring SWI/SNF Alterations
Cited by 0
Semantic Scholar
Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609)
Cited by 0
Semantic Scholar
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment
Cited by 0
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(713)
Lung Cancer Treatments and Mutations
(329)
Cancer Immunotherapy and Biomarkers
(238)
Colorectal Cancer Treatments and Studies
(209)
Chronic Lymphocytic Leukemia Research
(195)
Affiliations
Florida State University
University of North Carolina at Chapel Hill
University of Nebraska–Lincoln
Roche (Switzerland)
University of Nebraska at Omaha